Retatrutide
Triple GLP-1 / GIP / glucagon receptor agonist
A triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. It is studied for substantial weight reduction and broad metabolic effects, with the glucagon arm of interest for energy expenditure research.
Commonly explored for
Fat loss
Recomposition
Cardiovascular
Hormonal balanceVerified sellers coming soon
Brands and verified sellers for this compound will appear here as they join the platform.
Educational information only. Peptide 2.0 is an information and marketplace platform, not a pharmacy, and does not make medical claims.